PRF Technologies (PRFX) Stock Price

PRF Technologies Price

NASDAQ·CLOSED
0.48
​
Market closed

PRF Technologies's net margin stands at -28,458.8%, down from -10,223.3% several years earlier.

PRF Technologies stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PRF Technologies business model & stock analysis

PainReform Ltd. develops reformulated pain therapeutics to extend efficacy, minimize adverse effects, and improve patient convenience. The company focuses on enhancing established pharmaceuticals through its proprietary technology, targeting faster recovery of motor function. Its products are designed for healthcare providers and patients seeking advanced pain management solutions. The business model centers on licensing its reformulation technology to pharmaceutical partners. These partners integrate PainReform's solutions into their existing drug portfolios, leveraging the technology to improve product performance without developing new compounds from scratch. The primary buyers are established pharmaceutical companies looking to extend patent life and enhance market competitiveness of their pain management drugs. PainReform's technology addresses key pain management challenges by prolonging drug effects and reducing side effects. This positions the company as a strategic partner for pharmaceutical firms aiming to optimize their therapeutic offerings. The target segments include chronic pain patients and healthcare systems seeking more effective and safer pain treatment options.

Frequently asked questions about PRF Technologies

6 analysts currently rate the PRF Technologies stock: 0 recommend buying, 3 holding and 3 selling.

Converted at the current exchange rate, the PRF Technologies share trades at 0.43 EUR (0.48 USD).

The PRF Technologies share (PRFX) is listed on 1 stock exchanges, including: NASDAQ (PRFX).

The revenue cannot currently be calculated for PRF Technologies.

The profit cannot currently be calculated for PRF Technologies.

The P/E ratio cannot be calculated for PRF Technologies at the moment.

The P/S cannot be calculated for PRF Technologies currently.

The Eulerpool Quality Score for PRF Technologies is 2/10.

The ISIN of PRF Technologies is IL0011651580. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of PRF Technologies is PRFX. The ticker symbol is used to trade PRF Technologies shares on the stock exchange.

Fair ValueTerminal
0.39 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
2,833.33 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Israel
Currency
USD
Initial public offering
Sep 1, 2020
ISIN
IL0011651580
Cusip
M77798128
Market capitalization
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
—
P/Se
—
EV/EBIT
0.76
P/B Ratio
0.04
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-56.49 %
Last updated Nov 22, 2026, 3:50 AM

PRF Technologies Peer Group

PRF Technologies Ticker

NASDAQ · PRFX

PRF Technologies FIGI

PRFX:US · BBG00VT0S8T0PRFX:UA · BBG00VT0S8V7PRFX:UC · BBG00VT0S8W6PRFX:UN · BBG00VT0S8Y4PRFX:UP · BBG00VT0S8Z3PRFX:UB · BBG00VT0S918PRFX:UM · BBG00VT0S936PRFX:UX · BBG00VT0S945PRFX:UR · BBG00VT0S954PRFX:UD · BBG00VT0S990PRFX:UF · BBG00VT0S9D5PRFX:VY · BBG00VT0S9F3